Most parents support random performance-enhancing drug tests in high school

Article

Three out of four parents support random testing of high school athletes for performance-enhancing drugs, but less than half believe there should be individual penalties for those who test positive, according to C.S. Mott Children's Hospital's National Poll on Children's Health.

Three out of four parents support random testing of high school athletes for performance-enhancing drugs, but less than half believe there should be individual penalties for those who test positive, according to C.S. Mott Children's Hospital's National Poll on Children's Health.

The poll results, released November 17, also show that nearly one out of ten parents of a high school athlete knows someone under 18 who has tried performance-enhancing drugs.

The findings come from a nationally representative household survey administered in August 2008 that include 332 parents with high school athletes.

Other statistics include:

  • 57% of parents have talked with their children about performance-enhancing drugs.


  • 97% of parents believe that high school coaches should be required to communicate the dangers of performance-enhancing drugs.


  • 76% of parents believe schools should be required to report the number and percentage of positive tests to the state.


  • 43% believe individual names of athletes of who test positive should be reported.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
© 2025 MJH Life Sciences

All rights reserved.